|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.293
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.267
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.232
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.184
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.170
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.160
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.156
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.151
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.150
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.147
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.142
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.142
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.134
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.133
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.127
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.124
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.123
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.120
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.120
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.118
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.118
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.109
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.109
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.109
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.106
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.105
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.102
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.101
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.099
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.096
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.092
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.092
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.091
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.090
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.090
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.089
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.089
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.089
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.087
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.085
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.084
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.083
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.082
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.081
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.081
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.080
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.080
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.078
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.077
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.077
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.076
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.075
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.071
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.071
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.071
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.071
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.069
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.068
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.068
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.067
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.067
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.067
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.066
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.065
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.064
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.064
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.063
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.063
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.062
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.061
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.061
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.059
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.059
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.059
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.059
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.057
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.057
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.056
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.055
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.055
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.055
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.055
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.054
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.054
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.053
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.053
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.053
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.052
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.052
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.052
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.052
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.051
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.051
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.051
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.051
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.050
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.048
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.048
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.048
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.048
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.048
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.047
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.047
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.046
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.046
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.046
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.046
|
|
|
|
protein n linked glycosylation
|
GO:0006487 |
12 |
0.045
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.045
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.045
|
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.045
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.045
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.044
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.044
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.044
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.043
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.043
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.042
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.042
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.042
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.042
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.041
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.041
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.041
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.040
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.040
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.040
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.040
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.040
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.039
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.039
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.039
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.039
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.039
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.039
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.039
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.039
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.038
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.038
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.038
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.038
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.038
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.038
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.037
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.037
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.037
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.037
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.037
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.037
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.037
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.037
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.037
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.037
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.036
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.036
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.036
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.035
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.035
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
10 |
0.035
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.035
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.034
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.034
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.034
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.034
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.034
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.034
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.034
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.034
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.033
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.033
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.033
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.032
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.032
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.032
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.031
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.031
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.031
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.031
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.031
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.031
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.031
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.031
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.031
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.030
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.030
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.030
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.030
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.030
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.030
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.030
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.029
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.029
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.029
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.029
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.029
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.028
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.028
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.028
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.028
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.028
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.028
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.028
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.028
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.028
|
|
|
|
alpha amino acid biosynthetic process
|
GO:1901607 |
15 |
0.027
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.027
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.027
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.027
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.027
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.027
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.027
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.026
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.026
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.026
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.026
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.026
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.026
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.026
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.025
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.025
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.025
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.025
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.025
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.025
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.024
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.024
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.024
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.024
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.024
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.024
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.024
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.023
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.023
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.023
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.023
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.023
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.023
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.023
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.023
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.023
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.023
|
|
|
|
regulation of serine type endopeptidase activity
|
GO:1900003 |
2 |
0.023
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.022
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.022
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.022
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.022
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.022
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.022
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.022
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.022
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.022
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.022
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.021
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
memory
|
GO:0007613 |
58 |
0.021
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.021
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.021
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.021
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.021
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.020
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.020
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.020
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.020
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.020
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.020
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.020
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.020
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.020
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.020
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.020
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.020
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.020
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.019
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.019
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.019
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.019
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.019
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.019
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.019
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.019
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.019
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.019
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.019
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.019
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.019
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.019
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.018
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.018
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.018
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.018
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.018
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.018
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.018
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.018
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.018
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.018
|
|
|
|
regulation of lipoprotein metabolic process
|
GO:0050746 |
4 |
0.018
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.018
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.018
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.017
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.017
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.017
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.017
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.017
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.017
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.017
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.017
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.017
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.017
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.017
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.017
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.017
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
|
response to chromate
|
GO:0046687 |
1 |
0.016
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.016
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.016
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.016
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.016
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.016
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.016
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.016
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.016
|
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.016
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.016
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.016
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.016
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.016
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.015
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.015
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.015
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.015
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.015
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.015
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.015
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.015
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.015
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.015
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
22 |
0.015
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.015
|
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.015
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.015
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.015
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.015
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.015
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.015
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.014
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.014
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.014
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.014
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.014
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.014
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.014
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.014
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.014
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.014
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.014
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.014
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.014
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.014
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.014
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.014
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.014
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
1 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.014
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.014
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.014
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.014
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.014
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.014
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.014
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.014
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
22 |
0.014
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.014
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.014
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.014
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.014
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.014
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.014
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.013
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.013
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.013
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.013
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.013
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.013
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.013
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.013
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.013
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.013
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.013
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.013
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.013
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.013
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.013
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.013
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.013
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.013
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.013
|
|
|
|
l ascorbic acid biosynthetic process
|
GO:0019853 |
3 |
0.013
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.013
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.013
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.013
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.013
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.013
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.012
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.012
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.012
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.012
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.012
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.012
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.012
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.012
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.012
|
|